Specifically, robust and consistent protective effects were observed for schizophrenia and anxiety disorders, as evidenced by significant associations across all datasets analyzed
But a class of medications, initially approved to treat diabetes, is closing the gap between the two ends of the obesity treatment spectrum: lifestyle modification and bariatric surgery
As always, consult your healthcare provider to determine whats right for your individual health needs and circumstances
The effectiveness of GLP-1 medications will vary from product to product, but most people can expect to see average weight loss results within eight to twelve weeks
Two residues with shorter side chains (I7 P and A13 P ) in GIP further weakened its binding to GLP-1R, consistent with the distinct cross-reactivity features of GIP and GCG with GLP-1R 5,6